Cosmos Health Inc (COSM) is undervalued and Henry Schein Inc (HSIC) is overvalued.
Against our estimates of intrinsic value, COSM trades at the wider discount: a margin of safety of +52%, against -48% for HSIC.
Values as of the 22 Sept 2026 close.
A 1.2x revenue multiple, discounted for its losses, values the shares at $0.73; the price of $0.35 is 52% below that value.
Leak Score 56/100 on 2 of 12 signals
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $58.94; the price of $87.43 is 48% above that value, and 79% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
| Metric | COSM | HSIC |
|---|---|---|
| Verdict | Undervalued | Overvalued |
| Price | $0.35 | $87.43 |
| Intrinsic value | $0.73 | $58.94 |
| Margin of safety | +52% | -48% |
| Leak Score | 56/100 (2/12) | 14/100 (3/12) |
| Market cap | $36M | $9.7B |
| Revenue growth, 5 years | 3.3% | 5.4% |
| Operating margin | -24.6% | 6.0% |
| Net margin | -33.1% | 3.0% |
| Return on equity | -104.0% | 12.2% |
| Debt to equity | 0.80 | 1.21 |
| P/E | — | 25.5x |
| Forward P/E | 5.1x | 14.6x |
| P/B | 1.4x | 3.1x |